cerrar
Tagged with Canada

Canada Pharma Data Snapshot 2020
Up-to-date data and infographics on the Canadian pharma market including an overview of market dynamics, pharmaceutical and biologics spending,…

Canada Pharma News Roundup September 2020
The latest news from Canadian pharma including deals for J&J’s and Novavax’s COVID-19 vaccines, an abrupt end to Canada’s participation in…

Drugmakers Push Back Against Canada’s New Pricing…
Pushback from drug companies on Canada’s newest drug pricing regulations has led the country's regulatory body to reconsider their implementation.…

Alzheimer’s Disease Treatment: Canadian-Led Innovation…
Dr Neil Cashman looks at the potential impact of US FDA approval for Biogen's aducanumab on the search for Alzheimer's Disease (AD) treatments, and…

Global Pharma has Reinvented R&D: Will Canadian Start-Ups…
John L. Wallace of Antibe Therapeutics highlights how Canadian innovation stands to put the country at the forefront of the next wave of global…

A New Approach to Rare Diseases in Canada
Pamela Fralick of Innovative Medicines Canada (IMC) advocates for a collaborative multi-stakeholder approach to better tackle rare diseases in Canada.…

Biogen Canada’s Marina Vasiliou: A 100% Commitment to…
Marina Vasiliou took the reins as managing director of Biogen Canada in November 2017 after a long and varied career at MSD in a wide variety of…

Biosimilars and Biologics: Canada
Biosimilars and biologics in Canada: A legal guide. Prepared in association with Fasken, a leading global law firm, this is an extract from The…

Localization: Canada
Want to know more about the localization in Canada? Read on! Prepared in association with Fasken, a leading global law firm, this is an extract…

Orphan Drugs and Rare Diseases: Canada
All legal aspects surrounding orphan drugs and rare diseases in Canadian Pharma. Prepared in association with Fasken, a leading global law firm, this…

Collective Impact in the Health Charity Sector
Diabetes Canada's Jan Hux outlines how her organization has been able to shift from small, local programs to driving change at a much larger level via…

Patents: A Key Factor in Winning the Cannabis Arms Race
A new white paper from Fasken law firm asserts that the early filing of patents for innovative products is crucial for companies hoping to succeed in…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here